Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Rheumatol ; 42(6): 1205-1214, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38910579

ABSTRACT

OBJECTIVES: The objective of this study is to ascertain the disparities in demographic features and biochemical profiles between individuals diagnosed with fibromyalgia (FM) and a control group of healthy individuals. METHODS: This retrospective, cross-sectional study compared the demographic, biochemical, metabolic, and inflammatory indexes and rates of 174 FM patients diagnosed using the American College of Rheumatology 2016 diagnostic criteria between January 2023 and January 2024, and 186 healthy control groups. RESULTS: There was no difference between the FM and control groups in terms of alcohol consumption, marital status, or diabetes mellitus. The smoking rate is higher, and the educational level was found to be lower for FM versus the control. There was no significant difference between FM and controls regarding waist-height ratio, triglyceride-glucose index, plasma atherogenic index, vitamin B12, and folate levels. Monocyte HDL ratio, cardiometabolic index, magnesium, HbA1c, and ferritin levels were significantly higher in the control than in FM (p<0.001, p=0.039, p=0.007, p<0.001, p<0.001, respectively). C-reactive protein, erythrocyte sedimentation rate, systemic immune-inflammatory index, neutrophil-lymphocyte rate, platelet lymphocyte rate, and vitamin D levels were found to be higher in FM compared to control (p=0.001, p=0.032, p=0.003, p=0.030, p=0.003, p<0.001, respectively). A weak positive correlation was observed between the fibromyalgia impact questionnaire (FIQ) score and disease duration, as well as between pain degree and ESR, and pain degree and CRP. The study revealed a weak inverse relationship between Widespread Pain Index (WPI) and waist circumference. CONCLUSIONS: This study highlights fthe association f ibromyalgia with elevated inflammatory markers, altered metabolic parameters, and specific demographic characteristics.


Subject(s)
Biomarkers , Fibromyalgia , Humans , Fibromyalgia/blood , Fibromyalgia/epidemiology , Fibromyalgia/diagnosis , Retrospective Studies , Female , Cross-Sectional Studies , Male , Middle Aged , Adult , Biomarkers/blood , Inflammation/blood , Inflammation/epidemiology , Inflammation Mediators/blood , Case-Control Studies
2.
Metab Syndr Relat Disord ; 22(4): 269-275, 2024 May.
Article in English | MEDLINE | ID: mdl-38252497

ABSTRACT

Background: The risk of atherosclerosis is increased in individuals with rheumatological disease. The objective of this study is to examine the heightened susceptibility to atherosclerosis in persons afflicted with rheumatological disorders. This study aimed to assess the impact of anti-tumor necrosis factor (anti-TNF) medication on the plasma atherogenic index (PAI) in persons diagnosed with rheumatological disease. Methods: This study used a retrospective cross-sectional design to investigate a cohort of 136 patients with rheumatological disease who were undergoing anti-TNF therapy (Group 1), as well as a comparison group of 117 patients getting conventional therapy (Group 2). Measurements of PAI were conducted at the initial baseline and again at the sixth month of treatment. Results: Initially, there was no statistically significant disparity observed in PAI values between the two cohorts. After a period of 6 months, a notable reduction in PAI was identified in the group receiving anti-TNF medication (P = 0.01), while no significant alteration was detected in the group receiving conventional treatment. Conclusion: It provides findings showing that anti-TNF therapy can reduce the PAI in individuals with rheumatological disease. This may indicate a potential cardiovascular protective effect of anti-TNF therapy.


Subject(s)
Atherosclerosis , Rheumatic Diseases , Tumor Necrosis Factor-alpha , Humans , Male , Retrospective Studies , Female , Atherosclerosis/blood , Atherosclerosis/etiology , Atherosclerosis/drug therapy , Atherosclerosis/epidemiology , Middle Aged , Rheumatic Diseases/drug therapy , Rheumatic Diseases/blood , Rheumatic Diseases/complications , Cross-Sectional Studies , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Antirheumatic Agents/therapeutic use , Aged , Treatment Outcome
3.
Int J Rheum Dis ; 26(8): 1612-1614, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36876832

ABSTRACT

Systemic lupus erythematosus (SLE) is a systemic autoimmune complex disease that affects any organ, characterized by immune complex formation and autoantibody production. Lupus vasculitis begins at a young age. These patients generally have a longer disease duration. Ninety percent of cases in lupus-associated vasculitis present with cutaneous vasculitis. Disease activity, severity, organ involvement, response to treatment and drug toxicity determine the frequency of outpatient control in lupus. Depression and anxiety are observed more frequently in SLE than in the normal population. Our case, it is an example of the patient's disruption of controls due to psychological trauma and that lupus can cause serious cutaneous vasculitis. In addition, psychiatric evaluation of lupus cases from the time of diagnosis may have a positive effect on the prognosis.


Subject(s)
Lupus Erythematosus, Systemic , Skin Diseases, Vascular , Systemic Vasculitis , Vasculitis , Humans , Vasculitis/diagnosis , Vasculitis/drug therapy , Vasculitis/etiology , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/drug therapy , Skin Diseases, Vascular/complications , Prognosis
4.
Int J Rheum Dis ; 26(5): 954-956, 2023 May.
Article in English | MEDLINE | ID: mdl-36599812

ABSTRACT

Hemophilia is a rare inherited disease which causes bleeding due to Factor VIII or Factor IX deficiency. It is usually X-linked recessive and typically affects males. Arthropathy occurs as a result of cartilage damage and chronic synovitis due to recurrent intra-articular bleeding in hemophilic patients and is mostly seen in the knee, shoulder, hip and ankle joints. There are many other diseases that cause chronic synovitis ankylosing spondylitis (AS), which is a subtype of spondyloarthropathies that cause chronic low back pain, more common in men younger than 45 years of age. In addition to axial involvement, peripheral arthritis, uveitis, enthesitis and dactylitis can be seen. Although the etiology is not fully known, genetic and environmental factors are responsible for the pathogenesis. In this study, we aimed to present congenital hemophilia and AS coexistence in a 22-year-old male patient.


Subject(s)
Arthritis , Hemophilia A , Spondylitis, Ankylosing , Synovitis , Male , Humans , Young Adult , Adult , Spondylitis, Ankylosing/complications , Hemophilia A/complications , Hemophilia A/genetics , Synovitis/complications , Hemarthrosis/complications , Arthritis/complications , Hemorrhage
5.
Turk Thorac J ; 22(4): 346-352, 2021 Jul.
Article in English | MEDLINE | ID: mdl-35110253

ABSTRACT

The novel coronavirus disease (COVID-19) is similar to connective tissue disease-associated interstitial lung diseases (CTD-ILD) in many aspects. However, patients with CTD-ILD have required particular attention during the pandemic since they are at high risk due to -immunosuppressive treatments. Thus, prompt decisions for diagnosis and treatment initiation have become more important than earlier for these patients during the pandemic. Radiological perspectives have become inevitable for the differential diagnosis of this group ¬during the pandemic, particularly to obtain rapid and accurate results that allow the physicians to start treatment immediately. However, in addition to radiological images, a definitive diagnosis also requires access to extensive information regarding patient history, including characteristics of comorbidities, and clinical and serological findings. Consequently, the differential diagnosis of COVID-19 and CTD-ILD can yield accurate treatment regimens that differ greatly between the 2 diseases, and also prevent the spread of the outbreak with COVID-19 patients treated under isolation.

7.
J Med Case Rep ; 3: 7315, 2009 Sep 17.
Article in English | MEDLINE | ID: mdl-19918271

ABSTRACT

INTRODUCTION: Hepatic encephalopathy may be initiated by many factors such as gastrointestinal bleeding, infections, fluid and electrolyte disturbances. Hypokalemia is one of the most commonly encountered electrolyte abnormalities causing hepatic encephalopathy in patients with cirrhosis. CASE PRESENTATION: We present the case of a 62-year-old Caucasian man with decompensated liver cirrhosis having multiple episodes of hepatic encephalopathy precipitated by vomiting. He had an incisional hernia at the right lumbar region. A barium contrast study of the small intestine and magnetic resonance imaging showed that the hernial sac included gastric antrum and bowel. We observed that hepatic encephalopathy coincided with hypokalemia as a result of a large volume of vomiting triggered by the collapsed hernial sac. Hepatic encephalopathy was resolved by administration of intravenous potassium. CONCLUSION: This case illustrates that a hernia causing a large volume of vomiting may be a precipitant factor in the development of hepatic encephalopathy.

8.
Eurasian J Med ; 40(3): 127-32, 2008 Dec.
Article in English | MEDLINE | ID: mdl-25610046

ABSTRACT

OBJECTIVE: In the present study, we aimed to evaluate the morphological and functional characteristics in symptomatic and asymptomatic smokers in comparison to nonsmokers in order to gain better understanding of the pathogenesis and early diagnosis of Chronic Obstructive Pulmonary Disease (COPD). MATERIALS AND METHODS: A Randomized, double-blind, placebo -controlled, parallel-group trial vas performed. PATIENTS AND INTERVENTIONS: A total of 50 male patients (40 smokers and 10 non-smokers) who completed a questionnaire, between the ages of 18-60 (mean age 32), were included the study. Of the smokers, 23 were symptomatic, and 17 were asymptomatic. High-resolution computerized tomography (HRCT) and pulmonary function tests (PFTs) were performed in all cases. RESULTS: In the evaluation of all smokers, a comparison of the PFTs and morphological changes revealed a significant correlation between all morphological parameters and ΔN2/l. Although a relationship was found between the smoking score and the closing volume (CV), ΔN2/l and anatomic dead space (ADS) in all cases, the smoking score was significantly correlated with only the CV in symptomatic cases and with only the ADS in asymptomatic cases. There was a positive correlation between the emphysema parameters on HRCT and smoking, but no correlation was found between the parameters and the pulmonary function tests. CONCLUSION: The relationship between morphology and function is better, although different, in the asymptomatic period of lung injury caused by smoking compared with the symptomatic period, and the relationship is increasingly weakened in the further stages of the disease.

SELECTION OF CITATIONS
SEARCH DETAIL
...